[HTML][HTML] Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines
H Huang, S Wei, X Wu, M Zhang, B Zhou… - Toxicology and Applied …, 2023 - Elsevier
The pathophysiological mechanism of hepatic fibrosis (HF) is related to the excessive
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines.
H Huang, S Wei, X Wu, M Zhang, B Zhou… - Toxicology and …, 2023 - europepmc.org
The pathophysiological mechanism of hepatic fibrosis (HF) is related to the excessive
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines
H Huang, S Wei, X Wu, M Zhang… - Toxicology and …, 2023 - ui.adsabs.harvard.edu
The pathophysiological mechanism of hepatic fibrosis (HF) is related to the excessive
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines
H Huang, S Wei, X Wu, M Zhang… - Toxicology and …, 2023 - pubmed.ncbi.nlm.nih.gov
The pathophysiological mechanism of hepatic fibrosis (HF) is related to the excessive
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …
activation of the DNA repair enzyme poly ADP-ribose polymerase-1 (PARP-1). The drugs …